stars 1 stars 2 stars 3

Davol was founded in Providence, RI in 1874. Back then, the company supplied the medical community with hot water bottles and catheters. For the past 40 years, Davol has stood out as the market leader in providing solutions in soft tissue reconstruction solutions including products for hernia repair, specialized surgical procedures, fixation and biologic implants. Now a subsidiary of C.R. Bard, Inc., Davol continues to maintain its leadership position in the medical device industry with an expanded portfolio of proven, innovative solutions. These include a growing line of mesh prosthetics, biologic implants, surgical instruments and techniques for inguinal, ventral and other hernia repair procedures, plus a range of products for autotransfusion, hemostasis, laparoscopy, hysteroscopy, pulsed lavage and wound management. Researchers at Davol are constantly engaged in expanding the range of soft tissue repair, hemostasis and performance irrigation products aimed at providing exceptional reliability and value – qualities that clinicians, physicians and patients have come to depend on from Davol.

Bard Davol Questions

The Bard Davol annual revenue was $23 million in 2026.

Juan de Cardenas is the Director Product Development, Biosurgery Hemostats of Bard Davol.

55 people are employed at Bard Davol.

Bard Davol is based in Warwick, Rhode Island.

Top Bard Davol Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users